Psychological distress is common amongst those living with food allergy, but a new study co-led by a researcher at Aston University has shown that little support is available to those who are struggling.
4 burning questions about Amgen’s obesity drug, a potential Wegovy and Zepbound competitor
Amgen’s comments Thursday that it’s “very encouraged” by interim Phase 2 data for its obesity drug have quickly sparked immense investor interest in what could
May 3, 2024